News

William Morice II, M.D., Ph.D., president of Mayo Clinic Laboratories, shares his concerns about the VALID Act, which if passed would give the FDA oversight of laboratory-developed tests. VALID could hamper labs’ test development activity, increase costs for labs, and disproportionately affect smaller labs or those with fewer resources. It could also lead to more test development partnerships and lab collaboration.

Results of a new study by researchers at Mayo Clinic and Washington State University show that hydrogen peroxide-producing e-bandages may be an effective alternative to antibiotics for managing infected wounds.  

Topic highlights include: Mayo Clinic platform leader Dr. John Halamka turning 'healthcare data into wisdom', Loss of smell, taste no longer predominant COVID symptoms as virus continues to mutate, UK study: Don’t ruin your cookout by serving E. coli.

Mayo Clinic neuropathologist Caterina Giannini, M.D., Ph.D., received the American Association of Neuropathologists’ (AANP) award for Meritorious Contributions to Neuropathology during the AANP’s 98th annual meeting in June.

Topic highlights include: FDA to Authorize Novavax’s Covid-19 Vaccine, Newsom Announces California Will Produce Its Own ‘Low Cost’ Insulin, New dominant COVID-19 variant most transmissible yet, health officials say.

Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.

Mayo Clinic Laboratories has validated the Centers for Disease Control and Prevention's test kit for monkeypox and will begin to ramp up testing.

Top highlights include: Hospitals in less competitive regions have higher price transparency compliance, study finds, Many won’t rely on virtual options after COVID: AP-NORC poll, Exercise can cut all sorts of health risks for seniors. Here’s how to get going.

Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.

In June 2022, Mayo Clinic Laboratories announced forty-nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.

Top highlights include: CMS rolls out new payment model on improving cancer treatments, Mayo Clinic Waseca breaks ground on renovation project, Wearables are collecting a flood of data - an ambitious new study of pregnancy aims to prove that's valuable for health.

Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.

Top highlights include: A gull flaps its wings and a deadly virus explodes, Doctors increasingly prescribe time in nature to promote mental and physical health, Father's Day miracle: newborn receives organ donation right on time Minnesota.